share_log

昭衍新藥:(1)建議採納2022年A股限制性股票激勵計劃; (2)建議根據特別授權發行及授予A股限制性股票涉及關連交易; (3)建議採納2022年A股 限制性股票激勵計劃實施考核管理辦法; (4)建議授權董事會處理2022年A股 限制性股票激勵計劃相關事項; (5)建議採納2022年A股員工持股計劃

JOINN: (1) Proposed Adoption of the 2022 Restricted A Share Incentive Scheme; (2) Proposed Issue and Grant of Restricted A Shares under Specific Mandate involving Connected Transaction; (3) Proposed Adoption of the Assessment Administrative Measures on the

Aug 15, 2022 10:51
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more